RNA Therapeutics Market Growth and Future Outlook: Size, Trends & Opportunities The RNA Therapeutics industry is rapidly transforming the pharmaceutical and biotech landscape through innovative treatments targeting genetic disorders and diseases. The market dynamics reflect unprecedented growth driven by technological advancements, rising investments, and expanding applications. Current developments in RNA-based drugs underscore evolving market trends that signal substantial business growth and evolving market challenges. Market Size and Overview The global RNA Therapeutics market size is estimated to be valued at USD 4.2 million in 2026 and is expected to reach USD 160.0 million by 2032, exhibiting a compound annual growth rate (CAGR) of 68% from 2026 to 2032. This remarkable market growth is propelled by increasing adoption of RNA-based therapies for various conditions and improved delivery technologies. The expanding market scope includes numerous RNA therapeutics segments such as siRNA, mRNA, antisense oligonucleotides, and RNA aptamers, with continuous innovation fueling market revenue and driving industry size expansion. RNA Therapeutics Market – https://www.coherentmi.com/industry-reports/rna-therapeutics-market